Gut hormones (e.g., gastric inhibitory peptide and peptide YY) appear to increase circulating levels of pro-inflammatory cytokines, leading to persistent subclinical inflammation following an attack of AP [58,59]. The gene discussed is PYY; the disease is alkaline phosphatase measurement.